Medicine guide
Rivaroxaban-Amlodipin-Mepha 15 mg/10 mg
As listed in the register: Rivaroxaban-Amlodipin-Mepha 15 mg/10 mg, Tabletten
15 mg + 10 mg ·
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Rivaroxabanum + Amlodipinum
- Used in
- Blood, clotting and anaemia
- Made by
- Mepha Pharma AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Schlaganfallprophylaxe und Prophylaxe systemischer Embolien nicht-valvulärem Vorhofflimmern und Bluthochdruck bei Patienten, die bereits Rivaroxaban und Amlodipin als separate Tabletten in der gleichen Dosisstärke erhalten.
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Mepha Pharma AG |
|---|---|
| Active substance | Rivaroxabanum + Amlodipinum |
| Used in | Blood, clotting and anaemia |
| Strength | 15 mg + 10 mg |
| Classification | B01AF · Blood, clotting and anaemia |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Rivaroxaban-Amlodipin-Mepha 15 mg/10 mg, Tabletten |
| Packs | 30 Tablette(n) · 90 Tablette(n) |
| Zulassungsnummer | 69789 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg15 mg + 5 mgPrescription only Mepha Pharma AG · Rivaroxabanum + Amlodipinum · B01AFRivaroxaban-Amlodipin-Mepha 20 mg/5 mg20 mg + 5 mgPrescription only Mepha Pharma AG · Rivaroxabanum + Amlodipinum · B01AFRivaroxaban-Amlodipin-Mepha 20 mg/10 mg20 mg + 10 mgPrescription only Mepha Pharma AG · Rivaroxabanum + Amlodipinum · B01AF